GGrantIndex
← Search

RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines

$1,400,000U01FY2024IPCDC

University Of Michigan At Ann Arbor, Ann Arbor MI

Investigators

Linked publications & trials

View original record on NIH RePORTER →